KungHFBlauM, (1980) Regional intracellular pH shift: A proposed new mechanism for radiopharmaceutical uptake in brain and other tissues. J Nucl Med21: 147–152.
4.
KungHFMolnarMBillingsJBlauM, (1983) Synthesis and biodistribution of neutral lipid-soluble Tc-99m complexes which cross the blood-brain barrier. J Nucl Med24: 23.
5.
LassenNAAndersenARFribergHNeirinckxRD, (1987) Technetium-99m-HMPAO as a tracer of cerebral blood flow distribution: A kinetic analysis. J Cereb Blood Flow Metab7(suppl 1): S535.
6.
NarraRKKuczynskiBLSilvaDNunnADEcklemanWC, (1988) SQ32097: A potential Tc-99m labeled brain imaging agent. Seventh International Symposium on Radiopharmaceutical Chemistry, July 4–8, 1988 paper 26, Groningen Netherlands. J Label Comp Radiopharm (in press)
7.
NeirinckxRDCanningLRPiperIMNowotnikDPPickettREHolmesRAVolkertWAForsterAMWeisnerPSMarriottJAChaplinSB, (1987) TC-99m d,1-HM-PAO: A new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med28: 191–202.
8.
NowotnikDPCanningLRCummingSAHarrisonRCHigleyBNechvatalG, (1985) Development of a Tc-99m-labelled radiopharmaceutical for cerebral blood flow imaging. Nucl Med Commun6: 499–506.
9.
PetersAMDanpureHJOsmanJ, (1986) Clinical experience with 99m-Tc-hexamethylpropyleneamineoxime for labelling leucocytes and imaging inflammation. Lancet (2): 946–949.
10.
RavertHTBurnsHDHeindelNDKramerAVEppsLA, (1983) Synthesis of neutral, lipid soluble technetium complexes of bis(2-mercaptoethyl)amines. Nucl Med24: 10.
TroutnerDEVolkertWAHoffmanTJHolmesTJHolmesRA, (1983) A tetradentate amine complex of Tc-99m. J Nucl Med24: 10.
13.
WalovitchRCMakuchJKnapikG, (1988) Brain retention of Tc-99m-ECD is related to in vivo metabolism. J Nucl Med29: 747.
14.
WinchellHSHorstWDBraunL, (1980) N-Isopropyl (125I)p-iodoamphetamine: Single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. J Nucl Med21: 947–952.